Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fumi Sato

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Journal of Epidemiology|April 23, 2010
The Ohsaki Cohort 2006 Study: design of study and profile of participants at baselineShinichi Kuriyama, Naoki Nakaya, Kaori Ohmori-Matsuda, et al.
Journal of Medicinal Chemistry|August 8, 2024
Structure-Activity Relationship Studies in Benzothiadiazoles as Novel Vaccine AdjuvantsMasiel M Belsuzarri, Yukiya Sako, Tyler D Brown, et al.
ACS Chemical Biology|January 5, 2022
Small Molecule Calcium Channel Activator Potentiates Adjuvant ActivityTetsuya Saito, Nikunj M Shukla, Fumi Sato-Kaneko, et al.
ACS Chemical Biology|April 11, 2023
Identification of a Novel Small Molecule That Enhances the Release of Extracellular Vesicles with Immunostimulatory Potency via Induction of Calcium InfluxYukiya Sako, Fumi Sato-Kaneko, Nikunj M Shukla, et al.
Frontiers in Immunology|July 9, 2020
A Novel Synthetic Dual Agonistic Liposomal TLR4/7 Adjuvant Promotes Broad Immune Responses in an Influenza Vaccine With Minimal ReactogenicityFumi Sato-Kaneko, Shiyin Yao, Fitzgerald S Lao, et al.
SLAS Discovery : Advancing Life Sciences R & D|May 13, 2018
Identification of Compounds That Prolong Type I Interferon Signaling as Potential Vaccine AdjuvantsNikunj M Shukla, Kei-Ichiro Arimoto, Shiyin Yao, et al.
Frontiers in Immunology|October 15, 2021
Small Molecule Potentiator of Adjuvant Activity Enhancing Survival to Influenza Viral ChallengeTetsuya Saito, Yukiya Sako, Fumi Sato-Kaneko, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 3, 2021
Mitochondria-dependent synthetic small-molecule vaccine adjuvants for influenza virus infectionFumi Sato-Kaneko, Shiyin Yao, Fitzgerald S Lao, et al.
JCI Insight|September 22, 2017
Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancerFumi Sato-Kaneko, Shiyin Yao, Alast Ahmadi, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Journal of Epidemiology|April 23, 2010
The Ohsaki Cohort 2006 Study: design of study and profile of participants at baselineShinichi Kuriyama, Naoki Nakaya, Kaori Ohmori-Matsuda, et al.
Journal of Medicinal Chemistry|August 8, 2024
Structure-Activity Relationship Studies in Benzothiadiazoles as Novel Vaccine AdjuvantsMasiel M Belsuzarri, Yukiya Sako, Tyler D Brown, et al.
ACS Chemical Biology|January 5, 2022
Small Molecule Calcium Channel Activator Potentiates Adjuvant ActivityTetsuya Saito, Nikunj M Shukla, Fumi Sato-Kaneko, et al.
ACS Chemical Biology|April 11, 2023
Identification of a Novel Small Molecule That Enhances the Release of Extracellular Vesicles with Immunostimulatory Potency via Induction of Calcium InfluxYukiya Sako, Fumi Sato-Kaneko, Nikunj M Shukla, et al.
Frontiers in Immunology|July 9, 2020
A Novel Synthetic Dual Agonistic Liposomal TLR4/7 Adjuvant Promotes Broad Immune Responses in an Influenza Vaccine With Minimal ReactogenicityFumi Sato-Kaneko, Shiyin Yao, Fitzgerald S Lao, et al.
SLAS Discovery : Advancing Life Sciences R & D|May 13, 2018
Identification of Compounds That Prolong Type I Interferon Signaling as Potential Vaccine AdjuvantsNikunj M Shukla, Kei-Ichiro Arimoto, Shiyin Yao, et al.
Frontiers in Immunology|October 15, 2021
Small Molecule Potentiator of Adjuvant Activity Enhancing Survival to Influenza Viral ChallengeTetsuya Saito, Yukiya Sako, Fumi Sato-Kaneko, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 3, 2021
Mitochondria-dependent synthetic small-molecule vaccine adjuvants for influenza virus infectionFumi Sato-Kaneko, Shiyin Yao, Fitzgerald S Lao, et al.
JCI Insight|September 22, 2017
Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancerFumi Sato-Kaneko, Shiyin Yao, Alast Ahmadi, et al.
Pageof 7